참고문헌
- Abdel-Rahman WM, Ruosaari S, Knuutila S et al (2012). Differential roles of EPS8 in carcinogenesis: Loss of protein expression in a subset of colorectal carcinoma and adenoma. WJG, 18, 3896-903. https://doi.org/10.3748/wjg.v18.i29.3896
- Arroyo JD, Chevillet JR, Kroh EM et al (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. PNAS, 108, 5003-8. https://doi.org/10.1073/pnas.1019055108
- Baskerville S, Bartel DP (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA, 11, 241-7. https://doi.org/10.1261/rna.7240905
- Belkin DA, Mitsui H, Wang CQ et al (2013). CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma. JAMA Dermatol, 149, 178-86. https://doi.org/10.1001/jamadermatol.2013.1609
- Botti E, Spallone G, Moretti F et al (2011). Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. PNAS, 108, 13710-5. https://doi.org/10.1073/pnas.1110931108
- Boukamp P (2005). Non-melanoma skin cancer: what drives tumor development and progression?. Carcinogenesis, 26, 1657-67. https://doi.org/10.1093/carcin/bgi123
- Bruegger C, Kempf W, Spoerri I et al (2013). MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals. Exp Dermatol, 22, 426-8. https://doi.org/10.1111/exd.12153
- Butani A, Arbesfeld DM, Schwartz RA (2005). Premalignant and early squamous cell carcinoma. Clin Plast Surg, 32, 223. https://doi.org/10.1016/j.cps.2004.11.001
- Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- Cao G, Huang B, Liu Z et al (2010). Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem Bioph Res Co, 396, 978-82. https://doi.org/10.1016/j.bbrc.2010.05.037
- Chakraborty S, Swanson BJ, Bonthu N et al (2010). Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases. J Clin Pathol, 63, 579-84. https://doi.org/10.1136/jcp.2010.076125
- Chang SS, Smith I, Glazer C et al (2010). EIF2C Is Overexpressed and Amplified in Head and Neck Squamous Cell Carcinoma. Orl J Oto-Rhino-Lary, 72, 337-43.
- Chakraborty S, Swanson BJ, Bonthu N et al (2012). Differential expression of Fas family members and Bcl-2 family members in benign versus malignant epithelial ovarian cancer (EOC) in North Indian population. Mol Cell Biochem, 368, 119-26. https://doi.org/10.1007/s11010-012-1350-7
- Chen YJ, Wu CY, Chang CC et al (2008). Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol Ther, 7, 777-82. https://doi.org/10.4161/cbt.7.5.5768
- Croce CM (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet, 10, 704-14. https://doi.org/10.1038/nrg2634
- Dang C, Gottschling M, Manning K et al (2006). Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncol Rep, 16, 513-9.
- Das GD, Bhattacharjee B, Sen S et al (2012). Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions. Plos One, 7, 44678. https://doi.org/10.1371/journal.pone.0044678
- Endo-Munoz L, Dahler A, Teakle N et al (2009). E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation. Cancer Res, 69, 1800-8. https://doi.org/10.1158/0008-5472.CAN-08-2725
- Enerly E, Steinfeld I, Kleivi K et al (2011). miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. Plos One, 6, 16915. https://doi.org/10.1371/journal.pone.0016915
- Griewank KG, Murali R, Schilling B et al (2013). TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. Plos One, 8, 80354. https://doi.org/10.1371/journal.pone.0080354
- Hameetman L, Commandeur S, Bavinck JN et al (2013). Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer, 13, 58. https://doi.org/10.1186/1471-2407-13-58
- Heah KG1, Hassan MI, Huat SC (2011). p53 Expression as a Marker of Microinvasion in Oral Squamous Cell Carcinoma. Asian Pac J Cancer P, 12, 1017-22.
- Hsu SD, Lin FM, Wu WY et al (2011). Hsu SD, Lin FM, Wu WY et al: miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res, 39, 163-9. https://doi.org/10.1093/nar/gkq1107
- Huber MA, Kraut N, Beug H (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol, 17, 548-58. https://doi.org/10.1016/j.ceb.2005.08.001
- Inui M, Martello G, Piccolo S (2010). MicroRNA control of signal transduction. Nat Rev Mol Cell Bio, 11, 252-63. https://doi.org/10.1038/nrn2804
- Iorio MV, Ferracin M, Liu CG et al (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70. https://doi.org/10.1158/0008-5472.CAN-05-1783
- Johnson SM, Grosshans H, Shingara J et al (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635-47. https://doi.org/10.1016/j.cell.2005.01.014
- Karin M (1990). Too many transcription factors: positive and negative interactions. New Biol, 2, 126-31.
- Kathpalia VP, Mussak EN, Chow SS et al (2006). Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures. J Dermatol, 33, 309-18. https://doi.org/10.1111/j.1346-8138.2006.00075.x
- Kim SW, Ramasamy K, Bouamar H et al (2012). MicroRNAs miR-125a and miR-125b constitutively activate the NFkappa B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). PNAS, 109, 7865-70. https://doi.org/10.1073/pnas.1200081109
- Kozomara A, Griffiths-Jones S. (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 39, 152-7.
- Latchman DS (1997). Transcription factors: an overview. Int J Biochem Cell Biol, 29, 1305-12. https://doi.org/10.1016/S1357-2725(97)00085-X
- Le MT, Shyh-Chang N, Khaw SL et al (2011). Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving mirna-target gene pairs. Plos Genet, 7, 1002242. https://doi.org/10.1371/journal.pgen.1002242
- Le MT, Teh C, Shyh-Chang N et al (2009). MicroRNA-125b is a novel negative regulator of p53. Gene Dev, 23, 862-76. https://doi.org/10.1101/gad.1767609
- Lee YS, Kim HK, Chung SM et al (2005). Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the downregulation of putative targets during differentiation. J Biol Chem, 280, 16635-41. https://doi.org/10.1074/jbc.M412247200
- Lefort K, Brooks Y, Ostano P et al (2013). A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J, 32, 2248-63. https://doi.org/10.1038/emboj.2013.156
- Li Y, Guessous F, Zhang Y et al (2009). MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res, 69, 7569-76. https://doi.org/10.1158/0008-5472.CAN-09-0529
- Libermann TA, Zerbini LF (2006). Targeting transcription factors for cancer gene therapy. Curr Gene Ther, 6, 17-33. https://doi.org/10.2174/156652306775515501
- Loeb KR, Asgari MM, Hawes SE et al (2012). Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. Plos One, 7, 34422. https://doi.org/10.1371/journal.pone.0034422
- Lu J, Getz G, Miska EA et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Mandinova A, Kolev V, Neel V, et al (2009). A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans. J Clin Invest, 119, 3127-37. https://doi.org/10.1172/JCI38543
- Michael MZ, O' Connor SM, van Holst Pellekaan NG et al (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res, 1, 882-91.
- Moad AI, Tan ML, Kaur G et al (2012). Lack of increased P15INK4B protein expression in basal cell carcinomas. Asian Pac J Cancer Prev, 13, 6239-44. https://doi.org/10.7314/APJCP.2012.13.12.6239
- Moad AI, Lan TM, Kaur G, et al (2009). Immunohistochemical determination of the P15 (INK4b) protein expression in cutaneous squamous cell carcinoma. J Cutan Pathol, 36, 183-9. https://doi.org/10.1111/j.1600-0560.2008.00989.x
- Nam EJ, Yoon H, Kim SW et al (2008). MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res, 14, 2690-5. https://doi.org/10.1158/1078-0432.CCR-07-1731
- Park E, Liu B, Xia X et al (2011). Role of IKK alpha in skin squamous cell carcinomas. Future Oncol, 7, 123-34. https://doi.org/10.2217/fon.10.166
- Petitjean A, Achatz MI, Borresen-Dale AL et al (2007). TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene, 26, 2157-65. https://doi.org/10.1038/sj.onc.1210302
- Petitjean A, Mathe E, Kato S et al (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat, 28, 622-9. https://doi.org/10.1002/humu.20495
- Polakis P (2000). Wnt signaling and cancer. Gene Dev, 14, 1837-51.
- Poliseno L, Salmena L, Riccardi L et al (2010). Identification of the miR-106b-25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal, 3, 29.
- Qu H, Xu W, Huang Y et al (2011). Circulating miRNAs: promising biomarkers of human cancer. Asian Pac J Cancer Prev, 12, 1117-25.
- Raver-Shapira N, Marciano E, Meiri E et al (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell, 26, 731-43. https://doi.org/10.1016/j.molcel.2007.05.017
- Rodriguez A, Griffiths-Jones S, Ashurst JL et al (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res, 14, 1902-10. https://doi.org/10.1101/gr.2722704
- Sand M, Skrygan M, Georgas D et al (2012). Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinogen, 51, 916-22. https://doi.org/10.1002/mc.20861
- Sand M, Skrygan M, Georgas D et al (2012). Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. J Dermatol Sci, 68, 119-26. https://doi.org/10.1016/j.jdermsci.2012.09.004
- Sethupathy P, Corda B, Hatzigeorgiou AG et al (2006). TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA, 12, 192-7.
- Soussi T, Beroud C (2001). Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer, 1, 233-40. https://doi.org/10.1038/35106009
- Sowalsky AG, Alt-Holland A, Shamis Y et al (2010). RalA suppresses early stages of Ras-induced squamous cell carcinoma progression. Oncogene, 29, 45-55. https://doi.org/10.1038/onc.2009.307
- Suzuki HI, Yamagata K, Sugimoto K et al (2009). Modulation of microRNA processing by p53. Nature, 460, 529-111. https://doi.org/10.1038/nature08199
- Toriseva M, Ala-aho R, Peltonen S et al (2012). Keratinocyte Growth Factor Induces Gene Expression Signature Associated with Suppression of Malignant Phenotype of Cutaneous Squamous Carcinoma Cells. Plos One, 7, 33041. https://doi.org/10.1371/journal.pone.0033041
- Volinia S, Calin GA, Liu CG et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS, 103, 2257-61. https://doi.org/10.1073/pnas.0510565103
- Wang J, Lu M, Qiu C et al (2010). TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res 38: D119-122, 2010. Nucleic Acids Res, 38, 119-22.
- Wang NJ, Sanborn Z, Arnett KL et al (2011). Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. PNAS, 108, 17761-6. https://doi.org/10.1073/pnas.1114669108
- Wu Di, Guo Ze, Min Wei et al (2012). Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein. Exp Ther Med, 3, 437-42.
- Wu J, Zheng C, Fan Y et al (2014). Downregulation of MicroRNA-30 Facilitates Podocyte Injury and Is Prevented by Glucocorticoids. J Am Soc Nephrol, 25, 92-104. https://doi.org/10.1681/ASN.2012111101
- Xia YH, Li M, Fu DD et al (2013). Effects of PTTG downregulation on proliferation and metastasis of the SCL-1 cutaneous squamous cell carcinoma cell Line. Asian Pac J Cancer Prev, 14, 6245-8. https://doi.org/10.7314/APJCP.2013.14.11.6245
- Xie YJ, Long ZF, He XS (2013). Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis. Asian Pac J Cancer Prev, 14, 5637-44. https://doi.org/10.7314/APJCP.2013.14.10.5637
- Xu N, Zhang L, Meisgen F et al (2012). MicroRNA-125b Downregulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion. J Biol Chem, 287, 29899-908. https://doi.org/10.1074/jbc.M112.391243
- Yadav V, Yanez NC, Fenton SE et al (2010). Loss of protein kinase C delta gene expression in human squamous cell carcinomas - a laser capture microdissection study. Am J Pathol, 176, 1091-6. https://doi.org/10.2353/ajpath.2010.090816
- Yamakuchi M, Lowenstein CJ (2009). MiR-34, SIRT1 and p53 The feedback loop. Cell Cycle, 8, 712-5. https://doi.org/10.4161/cc.8.5.7753
- Yin VT1, Pfeiffer ML, Esmaeli B (2013). Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Recons, 29, 87-92. https://doi.org/10.1097/IOP.0b013e3182831bf3
- Zheng DJ, Yu GH, Gao JF et al (2013). Concomitant EGFR inhibitors combined with radiation for treatment of nonsmall cell lung carcinoma. Asian Pac J Cancer Prev, 14, 4485-94. https://doi.org/10.7314/APJCP.2013.14.8.4485
피인용 문헌
- MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4046-2
- Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes pp.1476-5594, 2017, https://doi.org/10.1038/onc.2017.315